The Pfizer New Haven Clinical Research Unit is conducting a clinical trial of a study drug for certain types of cancer and solid tumors. This study will look at the effects of the study drug when combined with another medication.
The study drug is being evaluated for the treatment of specific cancers and solid tumors, such as breast and prostate cancer. Millions of people are diagnosed with these cancers every year. Affected patients need effective and safe treatments, and healthy volunteers are an important part of developing these medicines.
Read more about this study below and see if you can make a difference as a healthy volunteer.
Who may participate
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Willing and able to comply with all study procedures
*participants may be eligible to receive a bonus for travel, ask our staff for details
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18-65 years
Sex
All sexes
Referral bonus
Up to $225
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 24 consecutive overnights. The morning after you arrive, you will receive a single oral dose of the study drug with food. Then, about 5 days later you will begin receiving daily doses of another medication up to twice a day for a total of 18 days. The dose of this medication will slowly increase over this time. On the 14th day of receiving this additional medication, you will receive another dose of the study drug with food. All doses will be given as tablets to swallow.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
*Some participants may be asked to return to the PCRU for a follow-up visit instead of competing a phone call for additional safety assessments. This visit will be compensated at a rate of $500.
Required overnight stays
24 consecutive overnights
Long-term follow up
1 phone call or visit*
How long is this study?
About 54 days
Compensation
Up to $10,900* upon completion of the study
All of the study procedures will be clearly explained to you during screening and can be viewed in the informed consent document. You may request a copy of the ICD prior to your scheduled screening if you would like additional time to review it.
The PCRU Loyalty Program has arrived!
Our new Loyalty Program offers unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.